Call for Abstract
Scientific Program
30th International Conference on Pediatrics & Adolescent health, will be organized around the theme “”
Pediatrics 2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pediatrics 2021
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Pediatrics track/session is aimed to focus on latest research, challenges and development in the research. We invite paediatricians, researchers, students, experts and practioners from academic, industry.
NIH support for pediatric research currently totals more than $4 billion. Aims to explore gaps in the overall pediatric research portfolio, and share best practices to advance science.
The objective of the General Pediatrics session is to disseminate new knowledge and new ideas to support the best public health and clinical decisions in current pediatrics by an accurate evaluation of risks and benefit-risk balance of various already existing or new strategies
Adolescent Medicine session is dedicated to improving the health and well-being of adolescents and young adults. We invite the researchers to present the new findings from the basic biological and behavioral sciences to public health and policy
Over 1.5 million adolescents and young adults aged 10–24 years died in 2019, nearly 5000 every day. Globally, there are 43 births per 1000 to girls aged 15–19 years per year. Half of all mental health disorders in adulthood start by age 14, but most cases are undetected and untreated
Pediatric Allergy and Immunology is designed to promote understanding and advance the treatment of respiratory, allergic, and immunologic diseases in children. We invite researchers work on Pediatric respiratory, allergy, and immunology specialists; health services specialists; and patient education researchers.
Children are diagnosed almost as frequently in a one-year period as adults, with approximately 7.1 million diagnosed, or 9.5 percent of the children in the population.
Pediatric Cardiology session discuss more about the diagnosis, management, and treatment of congenital heart disease, catheter intervention, cardiac surgery, fetal cardiology, pediatric cardiac intensive care, perioperative management, transition and problems, etiology and clinical manifestation of Kawasaki disease, acquired endocardial, myocardial or pericardial diseases, cardiomyopathy, diagnosis and management of pediatric chronic heart failure, pediatric cardiac transplantation and ventricular assist devices, pediatric arrhythmias including drug and nondrug therapies, pediatric pulmonary hypertension, and other cardiovascular-related diseases in fetuses, neonates, infants, children, adolescents, and adults.
New research shows resilience is common in people with congenital heart defects, which affects about 1 million children and 1.4 million adults in the United States.
